(NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced Gemini priming attenuates the ...
Built on the Gemini 2.0 model, these Gemini Robotics and Robotics-ER introduce new capabilities for controlling robots.